📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/20451253221113093

PubMed Identifier: 35874556

Publication URI: http://europepmc.org/abstract/MED/35874556

Type: Journal Article/Review

Volume: 12

Parent Publication: Therapeutic advances in psychopharmacology

ISSN: 2045-1253